seri
phenyloxyethyl
cinnamyl
deriv
substitut
uracil
synthes
found
exhibit
potent
activ
hivrt
hiv
replic
cell
cultur
gener
cinnamyl
deriv
prove
superior
phenyloxyethyl
deriv
howev
ethyl
uracil
exhibit
highest
activ
ec
lm
thu
confirm
fragment
nnrti
structur
regard
function
analogu
benzophenon
pharmacophor
typic
found
nnrti
n
n
disubstitut
uracil
nonnucleosid
inhibitor
revers
transcriptas
recent
report
unaid
reveal
million
hivinfect
patient
worldwid
number
annual
aidsrel
death
estim
million
million
death
overal
despit
develop
resist
mani
current
use
therapeut
hiv
revers
transcriptas
hivrt
remain
one
major
biolog
target
search
new
drug
hiv
hivrt
play
key
role
earli
stage
viral
replic
catalyz
rnadepend
synthesi
ribonucleas
h
dnadepend
dna
synthesi
provir
doublestrand
dna
compound
inhibit
hivrt
categor
nucleosidenucleotid
nrti
nonnucleosid
nnrti
inhibitor
nucleosidenucleotid
inhibitor
bind
activ
site
hivrt
nnrti
compris
structur
divers
spectrum
compound
capabl
initi
conform
chang
hivrt
bind
alloster
result
loss
hivrt
polymeras
activ
first
gener
nnrti
nevirapin
delavirdin
efavirenz
display
potent
activ
low
toxic
howev
due
high
genet
variabl
viru
resist
strain
one
point
mutat
rt
bind
pocket
rapidli
develop
first
gener
drug
prove
problemat
contrast
second
gener
fdaapprov
drug
includ
etravirin
rilpivirin
prove
highli
activ
wildtyp
frequent
mutant
hiv
strain
enhanc
safeti
profil
etravirin
rilpivirin
classifi
diarylpyrimidin
recent
biaryl
ester
increas
structur
divers
nnrti
inhibitor
fig
biaryl
ether
also
activ
wildtyp
mutant
rt
nanomolar
concentr
notabl
common
featur
two
nnrti
type
well
mani
other
particularli
benzophenon
deriv
presenc
three
aromat
ring
connect
short
linker
fig
relat
uracil
ring
system
found
mani
applic
construct
therapeut
use
molecul
attract
benzen
ring
increas
potenti
form
polar
intermolecular
interact
hydrogen
bond
interact
improv
enzym
affin
pharmacokinet
properti
target
compound
draw
upon
structur
featur
highli
activ
nnrti
previous
report
seri
benzophenon
deriv
pyrimidin
potent
antiretrovir
activ
like
origin
benzophenon
report
glaxosmithklin
fig
compound
featur
replac
distal
benzen
ring
uracil
logic
extens
previou
investig
herein
prepar
new
seri
compound
central
aromat
system
replac
uracil
fig
two
group
n
n
disubstitut
uracil
deriv
design
potenti
hivrt
inhibitor
shown
figur
n
atom
uracil
connect
aryl
fragment
threeatom
linker
contain
either
ether
oxygen
doubl
bond
alkenyl
moieti
gener
synthesi
first
group
target
compound
shown
scheme
variou
phenoxi
ethyl
uracil
obtain
accord
literatur
procedur
uracil
treat
appropri
benzyl
halid
dmf
presenc
k
co
give
target
compound
addit
ethyl
thymin
obtain
yield
ethyl
thymin
benzyl
chlorid
next
goal
studi
bridg
link
phenyl
residu
pyrimidin
n
synthes
deriv
ethyl
uracil
analog
manner
start
r
treatment
gave
deriv
fig
respect
interestingli
yield
compound
exceed
due
highli
favor
elimin
hydrogen
chlorid
observ
case
correspond
naphthyl
quinazolyl
deriv
also
sought
compound
prepar
use
addit
benzyl
substitu
uracil
ethyl
uracil
synthes
previous
laboratori
scheme
synthesi
analogu
shown
scheme
employ
dion
synthes
describ
kirincich
use
amin
dion
benzylamin
ethylen
glycol
result
deriv
treat
ethan
dmf
presenc
k
co
give
target
ethyl
dion
yield
synthesi
unsatur
target
undertaken
regard
deriv
synthes
two
step
shown
scheme
next
prepar
condens
trimethylsilyloxi
pyrimidin
cinnamyl
bromid
reaction
mixtur
reflux
h
give
yield
note
tlc
product
although
differ
synthet
rout
employ
physicochem
spectral
data
match
publish
previous
note
malik
et
al
initi
incorrectli
assign
structur
isomer
product
analogu
synthes
use
catalyst
product
isomer
appar
oxazolo
heterocycl
system
previous
report
skaric
next
treat
correspond
benzyl
halid
dmf
solut
presenc
k
co
molar
excess
room
temperatur
reaction
afford
correspond
deriv
uracil
yield
rang
uracil
shown
figur
obtain
similar
manner
yield
structur
synthes
compound
puriti
confirm
nmr
h
c
spectroscopi
tlc
massspectrometri
result
biolog
studi
reveal
sever
oxyethyl
cinnamyl
deriv
demonstr
activ
cell
cultur
prove
inhibitor
recombin
rt
vitro
howev
activ
lower
structur
relat
benzophenon
analogu
sever
known
nnrti
analysi
structureact
relationship
studi
reveal
highest
activ
display
uracil
bear
benzyl
group
regard
ethyl
uracil
exhibit
highest
activ
ec
lm
select
index
greater
see
tabl
compound
also
show
pronounc
inhibitori
activ
toward
rt
thu
confirm
mechan
activ
describ
compound
impli
fragment
nnrti
structur
regard
function
analogu
benzophenon
pharmacophor
although
latter
ensur
higher
antivir
activ
gener
cinnamyl
deriv
show
stronger
inhibitori
activ
hiv
hivrt
phenyloxyethyl
deriv
although
highest
activ
demonstr
phenoxyethylcontain
compound
tabl
activ
compound
test
doubl
mutant
rt
cell
cultur
howev
neither
show
activ
rang
concentr
studi
may
due
replac
anilid
fragment
linker
region
compar
benzophenon
nnrti
appar
result
loss
stack
interact
residu
analysi
inhibitori
activ
sever
compound
panel
singleand
doublemut
rt
reveal
n
n
disubstitut
uracil
retain
pronounc
activ
mutant
tabl
also
inhibit
rt
substitut
although
much
higher
concentr
compound
also
test
potenti
inhibitor
larg
panel
virus
includ
felin
corona
viru
herp
simplex
herp
simplex
vaccinia
viru
vesicular
stomat
viru
coxsacki
viru
respiratori
syncyti
viru
influenza
subtyp
influenza
subtyp
influenza
b
viru
sindbi
viru
punta
toro
viru
varicellazost
viru
human
cytomegaloviru
found
inact
except
four
cinnamyl
deriv
exhibit
notabl
antivir
activ
toward
human
cytomegaloviru
hcmv
tabl
order
ration
antihiv
activ
observ
molecular
model
studi
employ
crossdock
perform
autodock
vina
mgltool
softwar
preliminari
studi
show
abil
reproduc
experiment
observ
bind
mode
variou
rtnnrti
complex
pdb
entri
averag
rmsd
root
mean
squar
deviat
valu
low
accuraci
predict
mode
also
ascertain
visual
observ
accord
interactionsbas
accuraci
classif
protocol
activ
compound
seri
dock
wt
rt
rt
mutant
result
shown
figur
excel
correl
benzyl
correspond
moieti
origin
ligand
reveal
uracil
ring
also
form
close
hydrophob
contact
residu
omit
clariti
phenoxi
core
sandwich
residu
howev
complet
lack
interact
phenoxyethyl
side
chain
also
note
comparison
benzophenon
deriv
signific
differ
benzyl
benzoyl
core
orient
observ
although
overal
bind
mode
retain
strong
correl
benzophenon
uracil
carbonyl
group
also
noteworthi
hypothes
consequ
steric
prefer
depict
figur
unfavor
pstack
interact
associ
mutat
also
predict
along
lack
hbond
find
may
explain
dramat
loss
activ
mutant
hiv
strain
result
optim
region
pursu
cinnamyl
deriv
model
analog
manner
follow
similar
bind
pattern
data
shown
seen
tabl
presenc
methyl
group
posit
proxim
phenyl
ring
polar
group
posit
distal
phenyl
ring
r
lead
best
bind
ligand
explain
interact
group
ring
r
fig
proton
substitut
posit
disrupt
favor
chp
stack
compound
contrast
extend
group
posit
ring
r
favor
reach
solvent
access
area
entranc
pocket
absenc
bind
compound
due
steric
restrict
methyl
group
ortho
posit
r
ring
carbonyl
oxygen
central
uracil
ring
r
sinc
dens
pack
pocket
howev
appear
still
enough
degre
freedom
properli
orient
r
ring
one
methyl
group
ortho
posit
present
compound
seri
phenyloxyethyl
cinnamyl
deriv
substitut
uracil
synthes
found
inhibitori
hivrt
hiv
replic
cell
cultur
gener
cinnamyl
deriv
prove
somewhat
superior
phenyloxyethyl
deriv
howev
inhibit
mutant
rt
less
pronounc
addit
nnrticharacterist
mutat
present
enzym
moreov
doubl
mutant
detriment
activ
cinnamyl
deriv
show
moder
antihcmv
activ
howev
case
phenyloxyethyl
deriv
essenti
inact
effort
current
underway
improv
promis
activ
note
sever
compound
new
structur
modif
guid
addit
dock
effort
current
explor
exampl
may
prove
n
side
chain
optim
maxim
interact
amino
acid
landscap
use
hbond
donor
andor
introduc
conform
restrict
result
report
elsewher
obtain
activ
dna
purchas
ge
healthcar
littl
chalfont
uk
p
datp
cimmol
izotop
moscow
russia
nintaagaros
resin
rosetta
escherichia
coli
strain
novagen
madison
wi
reagent
highest
grade
obtain
sigma
st
loui
mi
chemic
obtain
commerci
sourc
use
without
purif
unless
otherwis
note
anhydr
dmf
isopropanol
ethylen
glycol
purchas
sigmaaldrich
co
anhydr
aceton
ch
cl
ethyl
acet
obtain
distil
p
nmr
spectra
regist
bruker
avanc
spectromet
mhz
h
mhz
c
cdcl
dmsod
tetramethylsilan
intern
standard
mass
spectra
regist
hewlett
packard
msd
finnigan
polari
q
massspectromet
ev
ion
chamber
temperatur
tlc
perform
merck
tlc
silica
gel
f
plate
elut
ethyl
acet
develop
iodin
melt
point
determin
glass
capillari
meltemp
laboratori
devic
inc
cia
yield
refer
spectroscop
h
c
nmr
homogen
materi
suspens
phenoxi
ethyl
uracil
g
mmol
r
co
g
mmol
dmf
ml
stir
h
benzyl
chlorid
ml
mmol
ad
mixtur
stir
temperatur
h
reaction
mixtur
cool
room
temperatur
pour
cold
h
ml
kept
h
result
precipit
filter
recrystal
mixtur
aceton
ml
h
ml
give
colorless
crystal
filter
airdri
give
g
mp
r
f
hexaneethyl
acet
synthes
similar
manner
give
synthes
similar
manner
give
synthes
similar
manner
give
synthes
similar
manner
give
g
mmol
white
crystal
mp
r
f
hexaneethyl
acet
mixtur
uracil
g
mmol
ammonium
chlorid
g
mmol
hexamethyldisilazan
ml
reflux
hr
exclus
moistur
clear
solut
obtain
excess
silyl
agent
remov
vacuum
residu
clear
oil
trimethylsilyloxi
pyrimidin
dissolv
ml
dri
distil
p
ad
cinnamyl
bromid
ml
mmol
solut
mixtur
reflux
h
n
reaction
mixtur
treat
isopropanol
ml
result
sediment
filter
wash
ethylacetatehexan
dri
room
temperatur
give
g
small
crystal
recrystal
iprohdmfwat
suspens
compound
g
mmol
r
co
g
mmol
dmf
ml
stir
h
benzyl
chlorid
ml
mmol
ad
mixtur
stir
temperatur
h
reaction
mixtur
cool
room
temperatur
pour
cold
h
ml
kept
h
aqueou
layer
decant
solid
residu
recrystal
mixtur
acetoneh
precipit
filter
airdri
give
concentr
test
compound
day
incub
number
viabl
cell
determin
use
bromid
mtt
method
select
character
mutant
viru
strain
perform
previous
compound
evalu
follow
virus
herp
simplex
viru
type
strain
ko
thymidin
kinasedefici
tk
ko
strain
resist
acv
acv
r
herp
simplex
viru
type
strain
lyon
g
varicellazost
viru
vzv
strain
oka
tk
vzv
strain
human
cytomegaloviru
hcmv
strain
davi
vaccinia
viru
lederl
strain
respiratori
syncyti
viru
rsv
strain
long
vesicular
stomat
viru
vsv
coxsacki
parainfluenza
influenza
viru
subtyp
influenza
viru
b
sindbi
punta
toro
antivir
assay
base
inhibit
virusinduc
cytopath
plaqu
format
human
embryon
lung
hel
fibroblast
african
green
monkey
cell
vero
human
epitheli
cell
hela
madindarbi
canin
kidney
cell
mdck
confluent
cell
cultur
microtit
plate
inocul
ccid
viru
ccid
viru
dose
infect
cell
cultur
plaqu
form
unit
pfu
vzv
presenc
vari
concentr
test
compound
viral
cytopath
plaqu
format
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
virusinduc
cytopathogen
viral
plaqu
format
plasmid
encod
subunit
wildtyp
revers
transcriptas
rt
mutant
form
describ
previous
similar
plasmid
encod
wildtyp
kind
gift
professor
le
grice
rt
express
rosetta
e
coli
strain
individu
subunit
rtharbor
cell
mix
togeth
heterodimer
rt
purifi
use
standard
ninta
agaros
procedur
rt
assay
use
activ
dna
perform
follow
standard
reaction
mixtur
contain
lg
activ
dna
lg
rt
lm
datp
lm
dctp
dgtp
dttp
lci
p
datp
trishcl
buffer
mm
ph
contain
also
mm
mgcl
kcl
test
compound
dissolv
dmso
ad
assay
final
dmso
concentr
reaction
mixtur
incub
min
appli
onto
whatman
filter
dri
air
filter
wash
trichloroacet
acid
trichloroacet
acid
ethanol
airdri
radioact
determin
perkin
elmer
tricarb
tr
liquid
scintil
counter
